|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income | |
| Adjustments to reconcile net income to net cash used in operating activities | |
| Dividend and interest income | |
| Gain on change in fair value of overallotment option | |
| Loss on change in fair value of overallotment option | |
| Changes in current assets and liabilities | |
| Prepaid expenses | |
| Accounts payable and accrued expenses | |
| Due to/from related party | |
| Due to related party | |
| Income taxes payable | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities | |
| Redemption of investments | |
| Net cash provided by (used in) investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from convertible note - related party | |
| Proceeds from promissory note - related party | |
| Payment of deferred offering costs | |
| Proceeds from issuance of common stock | |
| Repayment of promissory note | |
| Proceeds from issuance of Private Warrants | |
| Payment of offering costs on Public Units | |
| Net cash provided by (used in) financing activities | |
| Net change in cash | |
| Cash - beginning of the period | |
| Cash - end of the period | |
| Remeasurement of Class A common stock subject to possible redemption | |
| Deferred underwriting commissions | |
| Issuance of Representative Shares for services | |
| Directors' and officers' insurance fee paid by potential target company | |
| Offering costs included in accrued offering costs | |
| Non-cash investing and financing activities: | |
| Accretion of Class A common stock subject to possible redemption | |
| Deferred underwriting commissions | |
| Issuance of Representative Shares for services | |
| Directors’ and officers’ insurance fee paid by potential target | |
| Offering costs included in accrued offering costs |
Loading...
